@Article{Windorbska2007,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="11",
number="4",
year="2007",
title="Evaluation of diagnostic value of FDG-PET/CT study in detection of metastases in malignant melanoma patients",
abstract=" Aim:  Positron emission tomography is showing utility in the detection of metastatic tumors from multiple primary sites. Malignant melanoma is a kind of neoplasm which highly metabolized fluorodeoxyglucose (FDG). The purpose of the study was to determine sensitivity and specificity of FDG-PET/CT scanning for the detection of metastases in patients with malignant melanoma.    Material and methods:  We performed a retrospective study of FDG-PET/CT images in 39 melanoma patients. FDG-PET/CT examinations were conducted in the Department of Nuclear Medicine in Bydgoszcz between 2003 and 2005. FDG-PET/CT studies were performed to evaluate the actual clinical staging particularly in patients with suspected metastases in conventional radiological studies. Lymph node metastases were diagnosed in  8 patients. PET/CT images were performed on the integrated Biograph SL scanner (Siemens).    Results:  Positron emission tomography confirmed distant metastases identified in conventional imaging in 14 (36%) patients. In 19 (49%) patients FDG-PET/CT and conventional images both excluded distant metastases. Divergent results of standard radiological examinations and PET/CT scanning were obtained in 6 (15%) patients. FDG-PET/CT scanning had a sensitivity of 85% and specificity of 90%.    Conclusions:  FDG-PET/CT scanning is an extremely sensitive and specific diagnostic method allowing the proper staging in patients with suspicion of distant melanoma metastases.",
author="Windorbska, Wiesława
and Partyka, Anna
and Lewandowska, Aleksandra
and Małkowski, Bogdan",
pages="1200--203",
url="https://www.termedia.pl/Evaluation-of-diagnostic-value-of-FDG-PET-CT-study-in-detection-of-metastases-in-malignant-melanoma-patients,3,8373,1,1.html"
}